WO2014175428A1
|
|
Method for measuring emotion
|
WO2014081017A1
|
|
Fear or anxiety measuring system
|
WO2013172436A1
|
|
Novel glycosylated compound of crocin, method for producing same, and use for same
|
JP2014155534A
|
|
Balance function inspection device
|
JP2014104120A
|
|
Eyeball movement analysis system, eyeball movement diagnostic device, and eyeball movement analysis method
|
JP2014024800A
|
|
Hypnosis or sedation potentiator, and pharmaceuticals containing hypnosis or sedation potentiator
|
JP2013150553A
|
|
CARTPT mRNA EXPRESSION CELL LABELED ANIMAL AND SCREENING METHOD USING THE SAME
|
AU2011211648A1
|
|
Animal repellent
|
JP2010246547A
|
|
Mouse deleted in hematopoietic prostaglandin d synthetase gene and examination method using the same
|
JP2011246357A
|
|
Sleep improvement agent and sedative and their use
|
WO2011135632A1
|
|
Method for analyzing neural transmission of basal ganglia neural circuits
|
CN102348982A
|
|
Method for detecting muscle degenerative diseases, and method for determining therapeutic efficacy on the diseases
|
WO2010061574A1
|
|
Sleep-improving agent, sedative agent, and use thereof
|
JP2011083393A
|
|
Apparatus and method for automatically identifying sleep stage, and computer program for the same
|
JP2011019446A
|
|
Lesion model animal of myodegeneration disease, and method for producing the same
|
EP2650288A1
|
|
Sleep-improving agent
|
JP2009079033A
|
|
Osteoblast differentiation factor gene and its use
|
JP2009189688A
|
|
Fine probe, and measuring apparatus and method using the same
|
JP2009112402A
|
|
Sleep meter and sleep condition determination method
|
WO2007111350A1
|
|
Agent for inhibition of angiogenesis or mesenchymal-type or amoeboid-type invasion of cancer cell
|